Adeka (4401) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
7 Apr, 2026Executive summary
Net sales for the nine months ended December 31, 2025, were ¥296.7 billion, up 0.1% year-over-year; operating profit declined by 2.6% to ¥29.3 billion, while ordinary profit rose 2.4% to ¥30.3 billion; profit attributable to owners increased 3.4% to ¥19.8 billion, with EPS at ¥196.9.
Comprehensive income surged 51.8% year-over-year to ¥36.3 billion.
Financial highlights
Gross profit for the period was ¥84.8 billion, up from ¥84.0 billion year-over-year.
Basic earnings per share rose to ¥196.9, up ¥8.4 year-over-year.
Total assets increased to ¥558.4 billion from ¥543.1 billion as of March 31, 2025.
Operating margin for the nine months was approximately 9.9%.
Outlook and guidance
Full-year net sales forecast revised to ¥415.0 billion, up 1.9% year-over-year; operating and ordinary profit both forecast at ¥41.5 billion, up 1.2% and 5.5% respectively; profit attributable to owners projected at ¥25.5 billion, up 1.9% year-over-year.
Earnings per share forecast reduced by ¥1.8 to ¥257.7.
Annual dividend forecast raised to ¥104 per share, with a payout ratio target of 40% or more.
Recovery in polymer additives and semiconductor materials expected in Q4, with new product launches and market recovery anticipated.
Food products and life science segments' profit outlook remains unchanged.
Latest events from Adeka
- Profit and sales rose, led by Life Science, with stable outlook and higher dividend forecast.4401
Q1 202610 Mar 2026 - Life Science strength drove profit growth, offsetting Chemicals and Food Products weakness.4401
Q2 202610 Mar 2026 - Profits and sales grew, led by Chemicals and Food Products, with raised outlook and Life Science loss.4401
Q1 202510 Mar 2026 - Strategic investments and innovation in semiconductor materials target rapid global growth.4401
Investor presentation10 Mar 2026 - 3Q FY2024 saw higher sales and profits, driven by Chemicals and global expansion.4401
Q3 202510 Mar 2026 - Strong 1H FY2024 results and Chemicals growth led to higher guidance and dividend forecasts.4401
Q2 202510 Mar 2026 - Record sales and profit growth driven by Chemicals, with continued expansion and higher dividends forecast.4401
Q4 202510 Mar 2026